肺量计的盲区:振荡肺功能在社区病例发现中识别出与烟草剂量相关的小气道信号
The spirometric blind spot: oscillometry identifies a tobacco-dose-associated small-airway signal in community case-finding
希腊9个医疗点615名成人的横断面研究显示,社区病例发现中振荡肺功能检出小气道功能障碍27.2%(145/533),肺量计检出为14.1%(71/504),配对者阳性一致率仅22.8%(κ=0.055)。
Abstract
Small-airway dysfunction (SAD) may precede fixed airflow obstruction, but the clinical meaning of increased oscillometric detection in community settings remains uncertain. In this cross-sectional study, we evaluated an oscillometry-defined SAD phenotype, its concordance with spirometric indices, and its association with cumulative tobacco exposure within an open-access community respiratory case-finding programme. Adults attending nine healthcare sites in Greece underwent structured questionnaire assessment, respiratory oscillometry and spirometry. Oscillometric SAD was defined as any abnormal R5–R19, X5, AX or Fres z-score, whereas spirometric SAD was defined as FEF₂₅–₇₅ <65% predicted. Complete acceptable oscillometric classification was available in 533/615 participants and complete acceptable spirometry in 504/615. Oscillometric SAD was present in 145/533 (27.2%), spirometric SAD in 71/504 (14.1%), and fixed-ratio airflow obstruction in 18/504 (3.6%). Among 468 participants with complete paired oscillometric and spirometric classifications, positive agreement was low (22.8%; Cohen’s κ = 0.055). Each additional 10 pack-years increased the adjusted odds of oscillometric SAD by 19% among ever-smokers (aOR 1.19, 95% CI 1.05–1.36; p = 0.007) and by 18% among ever-smokers with FEV₁/FVC ≥ 0.70 (aOR 1.18, 95% CI 1.03–1.36; p = 0.020). SAD was also observed in 15/56 participants with asthma (26.8%) and 57/191 never-smokers without a prior chronic respiratory diagnosis (29.8%). Oscillometry therefore identified a tobacco-dose-associated mechanical phenotype that was incompletely captured by spirometric criteria, but its substantial prevalence outside COPD limits disease-specific interpretation.
Acknowledgements
The authors gratefully acknowledge the students of the Department of Nursing, University of Thessaly, for their contribution to the organisation and delivery of the community assessment sessions. We thank all participants and the physicians and healthcare professionals of the participating healthcare centres, including Aristeidis Vasilopoulos, Konstantinos Vatalis, Charalampos Kerasiotis, Emmanouil Manos, Maria Kalieri, Mirto Mpliziou, Eleni Mavraki, Maria Psiloutsikou, Chrysoula Papachristou, Athanasios Roustani, Elena Papakala, Zoi Panagioti, Efthimia Nikolaou, Georgios Kousko, Viorelis Drougias, Stergios Giotas and Professor Stylianos Loukidis, for their clinical and logistical support. We also acknowledge GlaxoSmithKline for supporting the acquisition of the Resmon PRO FULL V3 system and Chiesi for its financial contribution to implementation of the programme.
Funding
This work is supported by a Grant from the Hellenic Thoracic Society. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. (Grant Number: 14_2025). GlaxoSmithKline provided in-kind equipment support for the acquisition of the Resmon PRO FULL V3 system, and Chiesi provided financial support for implementation of the community programme.
Author information
Authors and Affiliations
Laboratory of Human Pathophysiology, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa, Greece
Ourania S. Kotsiou, Georgios I. Barkas, Kokona-Ioanna Diakomanoli, Marina Albanou, Vasiliki-Maria Dimtsi, Thomas Liaros, Evangelia-Maria Karanikola, Xenia Ilektra Tsiatsiou, Elisa Feizoula, Konstantina Gkouletza, Efthimia Laki, Chrysoula Nari, Maria Koukousa, Chaido-Maria Fanara, Alexandra Litso, Athina Plessa, Aikaterini Nikolaou, Panagiota Liaskou & Sonila Rousi
Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, University Hospital of Larissa, Larissa, Greece
Ourania S. Kotsiou, Konstantinos Passalidis, Evdoxia Gouta, Garyfallia Perlepe, Georgios I. Barkas, Paraskevi Kirgou, Maria Fotiou, Zoe Daniil & Konstantinos I. Gourgoulianis
Laboratory of Public Health, Department of Nursing, School of Health Sciences, University of Thessaly, Larissa, Greece
Dimitrios Papagiannis
Department of Nursing, University of Thessaly, Gaiopolis Campus, 41500, Larissa, Greece
Ourania S. Kotsiou
Authors
- Ourania S. Kotsiou
- Konstantinos Passalidis
- Evdoxia Gouta
- Garyfallia Perlepe
- Georgios I. Barkas
- Paraskevi Kirgou
- Dimitrios Papagiannis
- Maria Fotiou
- Kokona-Ioanna Diakomanoli
- Marina Albanou
- Vasiliki-Maria Dimtsi
- Thomas Liaros
- Evangelia-Maria Karanikola
- Xenia Ilektra Tsiatsiou
- Elisa Feizoula
- Konstantina Gkouletza
- Efthimia Laki
- Chrysoula Nari
- Maria Koukousa
- Chaido-Maria Fanara
- Alexandra Litso
- Athina Plessa
- Aikaterini Nikolaou
- Panagiota Liaskou
- Sonila Rousi
- Zoe Daniil
- Konstantinos I. Gourgoulianis
Corresponding author
Correspondence to Ourania S. Kotsiou.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The research protocol was approved by the Internal Committee of Ethics and Deontology of the Department of Medicine, School of Health Sciences, University of Thessaly, at its 3rd meeting on 8 May 2026 (protocol no. 1033). All participants received written and verbal study information and provided written informed consent before assessment. Data were pseudonymised and processed in accordance with the Declaration of Helsinki and the European General Data Protection Regulation.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kotsiou, O.S., Passalidis, K., Gouta, E. et al. The spirometric blind spot: oscillometry identifies a tobacco-dose-associated small-airway signal in community case-finding. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78211-z
Received: 22 August 2026
Accepted: 26 October 2026
Published: 29 October 2026
DOI: https://doi.org/10.1038/s41598-026-78211-z
Keywords
来源:Nature 健康护理主题 · nature.com